[HTML][HTML] Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials

C Ribera, JV Sánchez-Ortí, G Clarke, W Marx… - Neuroscience & …, 2024 - Elsevier
The use of probiotics, prebiotics, synbiotics or fermented foods can modulate the gut-brain
axis and constitute a potentially therapeutic intervention in psychiatric disorders. This …

The effectiveness of using cognitive behavioral therapy and internet-based cognitive behavioral therapy interventions on relapse prevention and severity of symptoms …

RH Haddad, BK Alhusamiah, RH Haddad… - Mental Health and …, 2024 - emerald.com
Purpose This study aims to evaluate and summarize the effectiveness of cognitive
behavioral therapy (CBT) and internet-based CBT (ICBT) interventions on relapse …

[HTML][HTML] Understanding depression beyond the “mind‐body” dichotomy

M Maj - World Psychiatry, 2023 - ncbi.nlm.nih.gov
In both the ICD-11 and the DSM-5, the core symptoms of depression are reported to be
depressed mood (eg, feeling sad, down or hopeless) and markedly diminished interest or …

Adherence to the ultra-processed dietary pattern and risk of depressive outcomes: Findings from the NutriNet Brasil cohort study and an updated systematic review …

AO Werneck, EM Steele, FM Delpino, MM Lane… - Clinical Nutrition, 2024 - Elsevier
Background & aims We aimed to analyze the prospective association between adherence to
the ultra-processed dietary pattern and risk of depressive outcomes using original data from …

[HTML][HTML] Research progress on antidepressant effects and mechanisms of berberine

Y Gao, K Nie, H Wang, H Dong, Y Tang - Frontiers in Pharmacology, 2024 - frontiersin.org
Depression, a global health problem with growing prevalence, brings serious impacts on the
daily life of patients. However, the antidepressants currently used in clinical are not perfectly …

Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review

M Di Vincenzo, V Martiadis, B Della Rocca… - Frontiers in …, 2024 - frontiersin.org
Introduction and aims Treatment-resistant depression (TRD) occurs when at least two
different antidepressants, taken at the right dosage, for adequate period of time and with …

[HTML][HTML] Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study

M Akter, ASM Roknuzzaman, M Shahriar, SMA Islam… - PloS one, 2024 - journals.plos.org
Background Major depressive disorder (MDD) is a common and debilitating mental illness
characterized by persistent feelings of sadness, hopelessness, and a lack of interest in daily …

[HTML][HTML] The clinical utility and relevance in clinical practice of DSM-5 specifiers for major depressive disorder: A Delphi expert consensus study

A Fiorillo, U Albert, B Dell'Osso, M Pompili… - Comprehensive …, 2024 - Elsevier
Major depressive disorder (MDD) is a heterogeneous syndrome, associated with different
levels of severity and impairment on the personal functioning for each patient. Classification …

Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients

Z Guo, T Long, J Yao, Y Li, L Xiao… - Frontiers in Pharmacology, 2024 - frontiersin.org
Background: Depression is a severe mental disorder that poses a significant threat to both
the physical and mental wellbeing of individuals. Currently, there are various methods for …

[HTML][HTML] A Delphi consensus on clinical features, diagnosis and treatment of major depressive disorder patients with anhedonia amongst psychiatrists in the Asia …

C Cheng, K Herr, HJ Jeon, T Kato, CH Ng… - Frontiers in …, 2024 - frontiersin.org
Background Anhedonia, a core diagnostic feature for major depressive disorder (MDD), is
defined as the loss of pleasure and interest in daily activities. Its prevalence in MDD patients …